New tools are needed for managing celiac sprue, a lifelong immune disease of the small intestine. Ongoing drug trials are also prompting a search for noninvasive biomarkers of gluten-induced intestinal change. We have synthesized and characterized noninflammatory gluten peptide analogs in which key Gln residues are replaced by Asn or His. Like their proinflammatory counterparts, these biomarkers are resistant to gastrointestinal proteases, susceptible to glutenases, and permeable across enterocyte barriers. Unlike gluten peptides, however, they are not appreciably recognized by transglutaminase, HLA-DQ2, or disease-specific T cells. In vitro and animal studies show that the biomarkers can detect intestinal permeability changes as well as glutenase-catalyzed gastric detoxification of gluten. Accordingly, controlled clinical studies are warranted to evaluate the use of these peptides as probes for abnormal intestinal permeability in celiac patients and for glutenase efficacy in clinical trials and practice.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3721637 | PMC |
| http://dx.doi.org/10.1016/j.chembiol.2009.07.009 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Non-celiac wheat sensitivity: differential diagnosis, triggers and implications.
Best Pract Res Clin Gastroenterol
June 2015
Institute for Translational Immunology and Research Center for Immunotherapy (FZI), University Medical Center, Johannes Gutenberg University, Mainz, Germany.
Non allergy-non-celiac wheat sensitivity (NCWS) has become a common and often overrated diagnosis. Skepticism mainly relates to patients with prominent intestinal symptoms in the absence of general or intestinal signs of inflammation. There is consensus that the major wheat sensitivities, celiac disease and wheat allergy, have to be ruled out which may be difficult for wheat allergy.
View Article and Find Full Text PDFNoninflammatory gluten peptide analogs as biomarkers for celiac sprue.
Chem Biol
August 2009
Department of Biochemistry, Stanford University, CA 94305, USA.
New tools are needed for managing celiac sprue, a lifelong immune disease of the small intestine. Ongoing drug trials are also prompting a search for noninvasive biomarkers of gluten-induced intestinal change. We have synthesized and characterized noninflammatory gluten peptide analogs in which key Gln residues are replaced by Asn or His.
View Article and Find Full Text PDFGeneralized acquired cutis laxa associated with coeliac disease: evidence of immunoglobulin A deposits on the dermal elastic fibres.
Br J Dermatol
July 1996
Department of Dermatology, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Acquired cutis laxa (ACL) is an uncommon elastolytic disorder of unknown aetiology. In rare instances, ACL has been reported in association with autoimmune diseases and dermal deposit of immunoglobulins, suggesting that destruction of elastic tissue may be immunologically mediated. We report a 35-year-old man with generalized acquired cutis laxa (GACL) associated with a persistent papular erythematous eruption that histopathologically showed some resemblance to dermatitis herpetiformis.
View Article and Find Full Text PDF[Antigliadin antibodies in rheumatoid arthritis].
Rev Rhum Ed Fr
March 1993
Service de Rheumátologie (1), CHRU, Brest.
To investigate the potential role of gliadin in the pathophysiology of some cases of rheumatoid arthritis (RA), the authors assayed antigliadin antibodies (AGAb) in RA patients. They used an ELISA to determine AGAb levels in 100 RA patients, a group of RA-free controls with a variety of inflammatory diseases (ID), and a group of controls with noninflammatory diseases (NID). The authors found no significant increase in AGAb titers in the RA patient group as compared with either control group.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!